Form 8-K MANNKIND CORP For: Feb 23

Go back to Form 8-K MANNKIND CORP For: Feb 23

MannKind (MNKD) PT Raised to $6.50 at Oppenheimer

February 27, 2023 9:27 AM EST

Oppenheimer analyst Steven Lichtman raised the price target on MannKind (NASDAQ: MNKD) to $6.50 (from $5.50) while maintaining a Outperform rating.

The analyst commented, "MNKD's 4Q22 sales were led by the second full quarter of Tyvaso DPI royalty; up to $9M from $6M in... More